Work Cited:

[1]American Heart Association. Cardiovascular Disease & Diabetes. N.p., n.d. Web. 11 July 2017. <http://www.heart.org/HEARTORG/Conditions/More/Diabetes/WhyDiabetesMatters/Cardiovascular-Disease-Diabetes_UCM_313865_Article.jsp#.WWTvKVLD-Uk>.

[2] Carey, D. G., A. B. Jenkins, L. V. Campbell, J. Freund, and D. J. Chisholm. “Abdominal Fat and Insulin Resistance in Normal and Overweight Women: Direct Measurements Reveal a Strong Relationship in Subjects at Both Low and High Risk of NIDDM.” Diabetes 45.5 (1996): 633-38. Web.

[3]”Diabetes Complications.” Mayo Clinic. Mayo Foundation for Medical Education and Research, 31 July 2014. Web. 18 July 2017. <http://www.mayoclinic.org/diseases-conditions/diabetes/basics/complications/CON-20033091>.

[4]Fox, Caroline S. “Cardiovascular Disease Risk Factors, Type 2 Diabetes Mellitus, and the Framingham Heart Study.” Trends in Cardiovascular Medicine 20.3 (2010): 90-95. Web.

[5]http://www.healthline.com/drugs/regular-insulin/injectable-solution#Highlights1

[6] Asano, Ricardo Yukio. “Acute effects of physical exercise in type 2 diabetes: A review.” World Journal of Diabetes 5.5 (2014): 659. Web.

[7] American Diabetes Association. “Standards of Medical Care in Diabetes—2017 : Summary of Revisions.” Diabetes Care 40.Supplement 1 (2016): n. pag. Web.

[8] “Type 1 Diabetes.” American Diabetes Association. N.p., n.d. Web. 07 Aug. 2017.

[9] [1] – Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes: prospective observational study. British Medical Journal 2000; 321: 405-412.

[10] Gladstone Institutes. “Key mechanism involved in Type 2 diabetes identified.” ScienceDaily. ScienceDaily, 28 March 2012. <www.sciencedaily.com/releases/2012/03/120328172259.htm>.

[11] “Treating Type 2 Diabetes: The Difference Between Children and Adults.” Avail Clinical Research. N.p., 29 Dec. 2014. Web. 09 Aug. 2017.